vimarsana.com
Home
Live Updates
Insulet's Omnipod 5 improves glycemic outcomes in very young
Insulet's Omnipod 5 improves glycemic outcomes in very young
Insulet's Omnipod 5 improves glycemic outcomes in very young children
Insulet (Nasdaq:PODD) announced data supporting the use of its Omnipod 5 automated insulin delivery system in young children.
Related Keywords
Louisiana ,
United States ,
New Orleans ,
American ,
Insulet Omnipod ,
Daniel Desalvo ,
Baylor College Of Medicine Dr ,
American Diabetes Association ,
Massachusetts Based Insulet ,
Scientific Sessions ,
Medical Director ,